Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Robin Gopal and Maria Zambon.
Robin Gopal
Connection Strength
1.650
Maria Zambon
  1. Antibodies to SARS-CoV-2 protect against re-infection during outbreaks in care homes, September and October 2020. Euro Surveill. 2021 02; 26(5).
    View in: PubMed
    Score: 0.232
  2. High prevalence of SARS-CoV-2 antibodies in care homes affected by COVID-19: Prospective cohort study, England. EClinicalMedicine. 2020 Nov; 28:100597.
    View in: PubMed
    Score: 0.228
  3. Investigation of SARS-CoV-2 outbreaks in six care homes in London, April 2020. EClinicalMedicine. 2020 Sep; 26:100533.
    View in: PubMed
    Score: 0.225
  4. Duration of infectiousness and correlation with RT-PCR cycle threshold values in cases of COVID-19, England, January to May 2020. Euro Surveill. 2020 08; 25(32).
    View in: PubMed
    Score: 0.224
  5. Severe respiratory illness caused by a novel coronavirus, in a patient transferred to the United Kingdom from the Middle East, September 2012. Euro Surveill. 2012 Oct 04; 17(40):20290.
    View in: PubMed
    Score: 0.130
  6. Comparability of six different immunoassays measuring SARS-CoV-2 antibodies with neutralizing antibody levels in convalescent plasma: From utility to prediction. Transfusion. 2021 10; 61(10):2837-2843.
    View in: PubMed
    Score: 0.060
  7. Cross sectional investigation of a COVID-19 outbreak at a London Army barracks: Neutralising antibodies and virus isolation. Lancet Reg Health Eur. 2021 Mar; 2:100015.
    View in: PubMed
    Score: 0.058
  8. Convalescent plasma therapy for the treatment of patients with COVID-19: Assessment of methods available for antibody detection and their correlation with neutralising antibody levels. Transfus Med. 2021 Jun; 31(3):167-175.
    View in: PubMed
    Score: 0.057
  9. Unexpected Receptor Functional Mimicry Elucidates Activation of Coronavirus Fusion. Cell. 2020 Dec 10; 183(6):1732.
    View in: PubMed
    Score: 0.057
  10. Increased risk of SARS-CoV-2 infection in staff working across different care homes: enhanced CoVID-19 outbreak investigations in London care Homes. J Infect. 2020 Oct; 81(4):621-624.
    View in: PubMed
    Score: 0.056
  11. Convalescent plasma treatment for SARS-CoV-2 infection: analysis of the first 436 donors in England, 22 April to 12 May 2020. Euro Surveill. 2020 Jul; 25(28).
    View in: PubMed
    Score: 0.056
  12. Snapshot PCR surveillance for SARS-CoV-2 in hospital staff in England. J Infect. 2020 Sep; 81(3):427-434.
    View in: PubMed
    Score: 0.056
  13. Unexpected Receptor Functional Mimicry Elucidates Activation of Coronavirus Fusion. Cell. 2019 02 21; 176(5):1026-1039.e15.
    View in: PubMed
    Score: 0.050
  14. Prophylactic and postexposure efficacy of a potent human monoclonal antibody against MERS coronavirus. Proc Natl Acad Sci U S A. 2015 Aug 18; 112(33):10473-8.
    View in: PubMed
    Score: 0.040
  15. A mouse model for Betacoronavirus subgroup 2c using a bat coronavirus strain HKU5 variant. mBio. 2014 Mar 25; 5(2):e00047-14.
    View in: PubMed
    Score: 0.036
  16. Evaluation of serologic and antigenic relationships between middle eastern respiratory syndrome coronavirus and other coronaviruses to develop vaccine platforms for the rapid response to emerging coronaviruses. J Infect Dis. 2014 Apr 01; 209(7):995-1006.
    View in: PubMed
    Score: 0.035
  17. Detection of a novel human coronavirus by real-time reverse-transcription polymerase chain reaction. Euro Surveill. 2012 Sep 27; 17(39).
    View in: PubMed
    Score: 0.032
  18. Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome. Lancet. 2003 Jul 26; 362(9380):263-70.
    View in: PubMed
    Score: 0.017
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.